Lv51
1090 积分 2023-08-09 加入
Discovery of ABBV-154, an anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody-Drug Conjugate (iADC)
1个月前
已完结
A first‐in‐human study of the novel immunology antibody–drug conjugate, ABBV‐3373, in healthy participants
1个月前
已关闭
Efficacy and Safety of ABBV‐3373, a Novel Anti–Tumor Necrosis Factor Glucocorticoid Receptor Modulator Antibody–Drug Conjugate, in Adults with Moderate‐to‐Severe Rheumatoid Arthritis Despite Methotrexate Therapy: A Randomized, Double‐Blind, Active‐Controlled Proof‐of‐Concept Phase IIa Trial
1个月前
已完结
Discovery of ABBV-3373, an Anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody Drug Conjugate
1个月前
已完结
Discovery of ABBV-154, an anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody-Drug Conjugate (iADC)
1个月前
已完结
Antibody-Drug Conjugates
1个月前
已关闭
Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study
2个月前
已完结
Antibody–drug conjugates come of age in oncology
2个月前
已完结
Exploring the next generation of antibody–drug conjugates
2个月前
已完结
Chronic Spontaneous Urticaria
2个月前
已完结
皖公网安备34019202002308
